Beamtree (ASX: BMT) – hospital knowledge management

ABOUT COMPANY

Beamtree Holdings (BMT) (https://beamtree.com.au/) develops and provides software services for the healthcare industry internationally. It provides a proprietary subscription-based Clinical Decision Support (CDS) system called “RippleDown”. The RippleDown Auditor, a knowledge-based system that allows various departments within a laboratory to audit data in real-time; and RippleDown Expert, an clinical decision support system that provides real-time patient monitoring, alerting, data mining, and reporting capability. It also provides LabQ, a data mining tool; PICQ, an auditing tool used in hospitals; RISQ, a tool for reviewing records in datasets to assess the quality of condition onset flags data and incidences of hospital-acquired complications; and Codexpert, a web-based eBook application that provides health-data classification reference for clinical coding of patient episodes.

In August 2021, the company acquired Potential(x) for 30m shares and $4m cash. It generates $11m revenue in FY21 and normalised EBITDA is $2.6m. The acquisition implied 1.8X FY21 revenue and 7.4x FY21 operational EBITDA. Potential(x) is an Australian pioneer in health data and provides most public and private hospitals in the country with cutting-edge comparative analytics that support improvements in quality and in the value of care. Over the 26 years of its operations, it has developed unrivaled expertise in health data collection, standardisation, and the benchmarking of clinical and financial outcomes.

In December 2022, the company signed a global distribution agreement with Abbott, which basically is a exclusive marketing agreement where all new sales in ANZ will be defined as Co-Sales, thus, all future revenue will be shared in various methods. The company forecasts to deliver over $10m plus revenue from 50-100 new large customers by the end of three-year term.